Cargando…

Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes

BACKGROUND: Despite potential glycemic benefits of continuous glucose monitor (CGM) use in young children with type 1 diabetes, psychosocial and behavioral challenges may interfere with sustained use. We developed a 5‐session family behavioral intervention (FBI) to support CGM use. OBJECTIVE: We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilliard, Marisa E., Commissariat, Persis V., Kanapka, Lauren, Laffel, Lori M., Levy, Wendy, Harrington, Kara, Anderson, Barbara J., Miller, Kellee M., DiMeglio, Linda A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542880/
https://www.ncbi.nlm.nih.gov/pubmed/35446449
http://dx.doi.org/10.1111/pedi.13349
_version_ 1784804250730102784
author Hilliard, Marisa E.
Commissariat, Persis V.
Kanapka, Lauren
Laffel, Lori M.
Levy, Wendy
Harrington, Kara
Anderson, Barbara J.
Miller, Kellee M.
DiMeglio, Linda A.
author_facet Hilliard, Marisa E.
Commissariat, Persis V.
Kanapka, Lauren
Laffel, Lori M.
Levy, Wendy
Harrington, Kara
Anderson, Barbara J.
Miller, Kellee M.
DiMeglio, Linda A.
author_sort Hilliard, Marisa E.
collection PubMed
description BACKGROUND: Despite potential glycemic benefits of continuous glucose monitor (CGM) use in young children with type 1 diabetes, psychosocial and behavioral challenges may interfere with sustained use. We developed a 5‐session family behavioral intervention (FBI) to support CGM use. OBJECTIVE: We report on the multi‐step development of the FBI, training interventionists, implementation in a 14‐site clinical trial, and participant satisfaction. METHODS: A multidisciplinary team created the FBI based on mixed‐methods (i.e., survey data, qualitative research) preliminary work with parents of young children. Investigators trained non‐physician staff to deliver the 5 sessions per an intervention manual. Trial participants received the FBI either during the first (FBI group, n = 50) or second 6‐months (Crossover group, n = 44) of the 1‐year trial. Investigators listened to session recordings to rate intervention fidelity, and participants rated satisfaction with the FBI. RESULTS: The complete 5‐session FBI was delivered to 89% of participants, in‐person (73%) or by telephone (23%). Sessions lasted 23 min on average, and fidelity was high across sessions. Over 80% of participants rated very high satisfaction with all aspects of the FBI and offered few recommendations for improvement. CONCLUSIONS: Having been developed based on experiences and input of families of young children with type 1 diabetes, the FBI represented a novel behavioral approach to enhance sustained CGM use during a challenging developmental period. Evidence of strong feasibility and acceptability supports its potential for implementation in research and clinical care. As diabetes technologies evolve, the FBI may continue to be refined to address parents' most relevant concerns.
format Online
Article
Text
id pubmed-9542880
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons A/S
record_format MEDLINE/PubMed
spelling pubmed-95428802022-10-14 Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes Hilliard, Marisa E. Commissariat, Persis V. Kanapka, Lauren Laffel, Lori M. Levy, Wendy Harrington, Kara Anderson, Barbara J. Miller, Kellee M. DiMeglio, Linda A. Pediatr Diabetes Behavioral Aspects of Diabetes BACKGROUND: Despite potential glycemic benefits of continuous glucose monitor (CGM) use in young children with type 1 diabetes, psychosocial and behavioral challenges may interfere with sustained use. We developed a 5‐session family behavioral intervention (FBI) to support CGM use. OBJECTIVE: We report on the multi‐step development of the FBI, training interventionists, implementation in a 14‐site clinical trial, and participant satisfaction. METHODS: A multidisciplinary team created the FBI based on mixed‐methods (i.e., survey data, qualitative research) preliminary work with parents of young children. Investigators trained non‐physician staff to deliver the 5 sessions per an intervention manual. Trial participants received the FBI either during the first (FBI group, n = 50) or second 6‐months (Crossover group, n = 44) of the 1‐year trial. Investigators listened to session recordings to rate intervention fidelity, and participants rated satisfaction with the FBI. RESULTS: The complete 5‐session FBI was delivered to 89% of participants, in‐person (73%) or by telephone (23%). Sessions lasted 23 min on average, and fidelity was high across sessions. Over 80% of participants rated very high satisfaction with all aspects of the FBI and offered few recommendations for improvement. CONCLUSIONS: Having been developed based on experiences and input of families of young children with type 1 diabetes, the FBI represented a novel behavioral approach to enhance sustained CGM use during a challenging developmental period. Evidence of strong feasibility and acceptability supports its potential for implementation in research and clinical care. As diabetes technologies evolve, the FBI may continue to be refined to address parents' most relevant concerns. John Wiley & Sons A/S 2022-05-19 2022-09 /pmc/articles/PMC9542880/ /pubmed/35446449 http://dx.doi.org/10.1111/pedi.13349 Text en © 2022 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Behavioral Aspects of Diabetes
Hilliard, Marisa E.
Commissariat, Persis V.
Kanapka, Lauren
Laffel, Lori M.
Levy, Wendy
Harrington, Kara
Anderson, Barbara J.
Miller, Kellee M.
DiMeglio, Linda A.
Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title_full Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title_fullStr Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title_full_unstemmed Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title_short Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
title_sort development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
topic Behavioral Aspects of Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542880/
https://www.ncbi.nlm.nih.gov/pubmed/35446449
http://dx.doi.org/10.1111/pedi.13349
work_keys_str_mv AT hilliardmarisae developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT commissariatpersisv developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT kanapkalauren developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT laffellorim developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT levywendy developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT harringtonkara developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT andersonbarbaraj developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT millerkelleem developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes
AT dimegliolindaa developmentanddeliveryofabrieffamilybehavioralinterventiontosupportcontinuousglucosemonitoruseinyoungchildrenwithtype1diabetes